Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07362992
Eligibility Criteria:
Inclusion Criteria:
* Women aged 18 to 51 years
* Singleton pregnancy
* Elective cesarean delivery scheduled at ≥37+0 weeks of gestation
* First or second cesarean delivery only
* Low transverse uterine incision planned
* Double-layer uterine closure using 1-0 Vicryl sutures
* Ability to provide written informed consent
Exclusion Criteria:
* Known allergy or hypersensitivity to tranexamic acid (TXA)
* History of bleeding or coagulation disorders
* Previous postpartum hemorrhage
* Placenta previa or placenta accreta spectrum
* Presence of uterine myomas
* Current use of anticoagulant or antiplatelet medications
* Planned or intraoperative conversion to general anesthesia
* Known uterine malformations
* Known bleeding tendency or thromboembolic disease
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
51 Years
Study:
NCT07362992
Study Brief:
Protocol Section:
NCT07362992